# Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

> **NCT01617239** · PHASE1 · COMPLETED · sponsor: **Crucell Holland BV** · enrollment: 84 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Virosomal influenza vaccine

## Key facts

- **NCT ID:** NCT01617239
- **Lead sponsor:** Crucell Holland BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-12
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01617239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01617239, "Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01617239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*